Cardio Diagnostics provides investor presentation; no material new facts disclosed

Cardio Diagnostics Holdings, Inc.

Company filed an Investor Presentation dated February 2025 under Item 7.01.
Presentation focuses on epigenetics and AI for cardiovascular medicine but contains no specific financial or operational metrics.
No changes to guidance, revenue, EPS, or business outlook were reported.
Presentation is available on the company's website for investor use.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.